Literature DB >> 9423862

Levels of expression and immunogenicity of attenuated Salmonella enterica serovar typhimurium strains expressing Escherichia coli mutant heat-labile enterotoxin.

M G Covone1, M Brocchi, E Palla, W Dias da Silveira, R Rappuoli, C L Galeotti.   

Abstract

The effects of heterologous gene dosage as well as Salmonella typhimurium strain variability on immune response toward both the heterologous antigen, the nontoxic mutant of the Escherichia coli heat-labile enterotoxin LTK63, and the carrier Salmonella strain have been analyzed. Effects of a single integration into the host DNA and different-copy-number episomal vectors were compared in S. typhimurium delta cya delta crp delta asd strains of two different serotypes, UK-1 and SR-11. Expression of the enterotoxin in the different Salmonella isolates in vitro was found to vary considerably and, for the episomal vectors, to correlate with the plasmid copy number. LTK63-specific serum immunoglobulin G (IgG) and mucosal immunoglobulin A (IgA) antibodies were highest in mice immunized with the high-level-expression strain. High anti-LTK63 IgG and IgA titers were found to correspond to higher anti-Salmonella immunity, suggesting that LTK63 exerts an adjuvant effect on response to the carrier. Statistically significant differences in anti-LTK63 immune response were observed between groups of mice immunized with the attenuated delta cya delta crp UK-1 and SR-11 derivatives producing the antigen at the same rate. These data indicate that the same attenuation in S. typhimurium strains of different genetic backgrounds can influence significantly the immune response toward the heterologous antigen. Moreover, delivery of the LTK63 enterotoxin to the immune system by attenuated S. typhimurium strains is effective only when synthesis of the antigen is very high during the initial phase of invasion, while persistence of the S. typhimurium strain in deep tissues has only marginal influence.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9423862      PMCID: PMC107881          DOI: 10.1128/IAI.66.1.224-231.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Studies on Escherichia coli enterotoxin.

Authors:  H W Smith; S Halls
Journal:  J Pathol Bacteriol       Date:  1967-04

2.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Authors:  C M Tsai; C E Frasch
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

3.  Kinetics of synthesis, processing, and membrane transport of heat-labile enterotoxin, a periplasmic protein in Escherichia coli.

Authors:  H Hofstra; B Witholt
Journal:  J Biol Chem       Date:  1984-12-25       Impact factor: 5.157

4.  Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines.

Authors:  S K Hoiseth; B A Stocker
Journal:  Nature       Date:  1981-05-21       Impact factor: 49.962

5.  Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic.

Authors:  R Curtiss; S M Kelly
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

6.  Construction of defined galE mutants of Salmonella for use as vaccines.

Authors:  D Hone; R Morona; S Attridge; J Hackett
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

7.  Construction and characterization of vaccine strains of Salmonella harboring mutations in two different aro genes.

Authors:  G Dougan; S Chatfield; D Pickard; J Bester; D O'Callaghan; D Maskell
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

8.  Sequence homologies between A subunits of Escherichia coli and Vibrio cholerae enterotoxins.

Authors:  E K Spicer; W M Kavanaugh; W S Dallas; S Falkow; W H Konigsberg; D E Schafer
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

9.  In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin.

Authors:  K L Bost; J D Clements
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

10.  Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin.

Authors:  W S Dallas; S Falkow
Journal:  Nature       Date:  1980-12-04       Impact factor: 49.962

View more
  16 in total

1.  Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA.

Authors:  J E Galen; J Nair; J Y Wang; S S Wasserman; M K Tanner; M B Sztein; M M Levine
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 2.  Enteric pathogens as vaccine vectors for foreign antigen delivery.

Authors:  Camille N Kotton; Elizabeth L Hohmann
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

3.  In vivo visualization of bacterial colonization, antigen expression, and specific T-cell induction following oral administration of live recombinant Salmonella enterica serovar Typhimurium.

Authors:  D Bumann
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.

Authors:  H Chen; D M Schifferli
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses.

Authors:  D Bumann
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

6.  Immunogenicity against human papillomavirus type 16 virus-like particles is strongly enhanced by the PhoPc phenotype in Salmonella enterica serovar Typhimurium.

Authors:  David Baud; Jalil Benyacoub; Véronique Revaz; Menno Kok; Françoise Ponci; Martine Bobst; Roy Curtiss; Pierre De Grandi; Denise Nardelli-Haefliger
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

Review 7.  Salmonella enterica serovar Typhi live vector vaccines finally come of age.

Authors:  James E Galen; Marcela F Pasetti; Sharon Tennant; Patricia Ruiz-Olvera; Marcelo B Sztein; Myron M Levine
Journal:  Immunol Cell Biol       Date:  2009-05-05       Impact factor: 5.126

8.  Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1.

Authors:  David Baud; Françoise Ponci; Martine Bobst; Pierre De Grandi; Denise Nardelli-Haefliger
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

9.  An enzymatically active a domain is required for cholera-like enterotoxins to induce a long-lived blockade on the induction of oral tolerance: new method for screening mucosal adjuvants.

Authors:  Kenneth C Bagley; Sayed F Abdelwahab; Robert G Tuskan; George K Lewis
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Adjuvant activity of a nontoxic mutant of Escherichia coli heat-labile enterotoxin on systemic and mucosal immune responses elicited against a heterologous antigen carried by a live Salmonella enterica serovar Typhimurium vaccine strain.

Authors:  H C Guillobel; J I Carinhanha; L Cárdenas; J D Clements; D F de Almeida; L C Ferreira
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.